Pariet

DRUG2 trials

Sponsors

Chang Gung Memorial Hospital, Eisai Korea Inc.

Conditions

Duodenal UlcerHelicobacter Pylori InfectionStomach Ulcer

Unknown Phase

Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment

CompletedNCT05152004

Chang Gung Memorial HospitalHelicobacter Pylori Infection

Start: 2018-09-01End: 2022-02-28Updated: 2022-07-20

A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer

CompletedNCT05208268

Eisai Korea Inc.Duodenal Ulcer, Stomach Ulcer

Start: 2020-07-23End: 2022-09-22Updated: 2022-11-22

Related Papers

The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial.

2023-05-033 citations